The role of lymphatic vessels in the heart

Pathophysiology

Volumn 17, Issue 4, 2010, Pages 307-314

  Cui, Yingjie ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Cardiac injury; Cardiac lymph flow; Cardiac lymphatic vessel; Lymphangiogenesis; Perivascular lymphatic vessel

Indexed keywords

ARTERY INJURY; BLOOD VESSEL INJURY; HEART BLOOD VESSEL; HEART DISEASE; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE CELL; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE INJURY; HEART PERFORMANCE; HUMAN; LYMPH FLOW; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHEDEMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; VALVULAR HEART DISEASE;

EID: 77955516510     PISSN: 09284680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pathophys.2009.07.006     Document Type: Review

References (59)

1. O. Rudbeck, Nova exervitatio anatomia exhibens ductus hepatico aquosos et vasa glandularum serosa, nunc primum inventa, aeneisque figures delineate, Arosiae, Upsala (in Swedish), 1653.
2. Harvey N.L., Oliver G. Choose your fate: artery, vein or lymphatic vessel?. Curr. Opin. Genet. Dev. 2004, 14:499-505.
3. Cui Y., Urschel J.D., Petrelli N.J. The effect of cardiopulmonary lymphatic obstruction on heart and lung function. Thorac. Cardiovasc. Surg. 2001, 45:35-40.
4. Cui Y. Confocal imaging: blood and lymphatic capillaries. TheScientificWorldJOURNAL 2006, 6:12-15.
5. Riquet M., Barthes F.L.P., Souilamas R., Hidden G. Thoracic duct tributaries from intrathoracic organs. Ann. Thorac. Surg. 2002, 73:892-899.
6. Patek P.R. The morphology of the lymphatics of the mammalian heart. Am. J. Anat. 1939, 64:203-234.
7. Eberth C.J., Belajeff A. Über die lymphgefasse des Herzens. Virchow's Arch. 1866, 37:124-131. (in German).
8. Miller A.J., Pick R., Katz L.N. Lymphatics of the mitral valve of the dog: demonstration and discussion of possible significance. Circ. Res. 1961, 9:1005-1009.
9. Miller A.J., Pick R., Katz L.N. The importance of the lymphatics of the mammalian heart: experimental observations and some speculations. Circulation 1964, 29:485-487.
10. Drinker C.K., Warren M.F., Maurer F.W., Mccarell J.D. The flow, pressure and composition of cardiac lymph. Am. J. Physiol. 1940, 130:43-55.
11. Allison P.R., Sabiston D.R. Experimental studies on the cardiac lymphatics. Surg. Forum. 1957, 8:271-274.
12. Saito H., Sato T., Miyazaki M. Extramural lymphatic drainage from the thoracic esophagus based on minute cadaveric dissections: fundamentals for the sentinel node navigation surgery for the thoracic esophageal cancers. Surg. Radiol. Anat. 2007, 29:531-542.
13. Gashev A.A. Lymphatic vessels: pressure- and flow-dependent regulatory reactions. Ann. N.Y. Acad. Sci. 2008, 1131:100-109.
14. Zawieja D.C. Lymphatic microcirculation. Microcirculation 1996, 3:241-243.
15. Zawieja D.C., Davis K.L., Schuster R., Hinds W.M., Granger H.J. Distribution, propagation, and coordination of contractile activity in lymphatics. Am. J. Physiol. 1993, 264:H1283-H1291.
16. Mislin H. Experimental detection of autochthonous automatism of lymph vessels. Experientia 1961, 17:29-30.
17. Mislin H., Rathenow D. Eksperimentelle Untersuchungen uber die bewegungskoordination der Lymphangione. Rev. Suisse Zool. 1962, 69:334-344. (in German).
18. Kampmeier O.F. On the lymph flow of the human heart, with reference to the development of the channels and the first appearance, distribution, and physiology of their valves. Am. Heart J. 1928, 4:210-222.
19. Anyukhovsky E.P., Sosunov E.A., Rosen M.R. Regional differences in electrophysiological properties of epicardium, midmyocardium, and endocardium in vitro and in vivo correlations. Circulation 1996, 94:1981-1988.
20. Maurer F.W. The effects of decreased blood oxygen and increased blood carbon dioxide on the flow and composition of cervical and cardiac lymph. Am. J. Physiol. 1940, 131:331-348.
21. Laine G.A., Granger H.J. Microvascular, interstitial, and lymphatic interactions in normal heart. Am. J. Physiol. 1985, 249:H834-H842.
22. Uhley H.N., Leeds S.E., Sung M.A., Patel S., Lobos E. The subendocardial lymphatics of the canine heart: a possible role of the lymphatics in the genesis of conduction disturbances and arrhythmias. Am. J. Cardiol. 1972, 29:367-371.
23. Stoll C., Alembik Y., Dott B., Kieffer P. Lymphedema combined with brachydactyly and tachycardia. Genet. Couns. 1998, 9:33-37.
24. Cui Y., Zhou D., Peng W., Liu T., Chen H. Determinants of perioperative morbidity and mortality after pneumonectomy. Thorac. Cardiovasc. Surg. 2004, 52:45-48.
25. Gitlitz G.F., Hurwitt E.S. Circulatory problems in the immediate postoperative period. Surg. Clin. North. Am. 1964, 44:505-535.
26. Miller A.J., DeBoer A., Palmer A. The role of the lymphatic system in coronary atherosclerosis. Med. Hypotheses 1992, 37:31-36.
27. Ludwig L.L., Schertel E.R., Pratt J.W., McClure D.E., Ying A.J., Heck C.F., Myerowitz P.D. Impairment of left ventricular function by acute cardiac lymphatic obstruction. Cardiovasc. Res. 1997, 33:164-171.
28. Sun S., Lie J. Cardiac lymphatic obstruction. Mayo. Clin. Proc. 1977, 52:785-792.
29. Miller A.J., Pick R., Katz L.N. Ventricular endomyocardial pathology produced by chronic cardiac lymphatic obstruction in the dog. Circ. Res. 1960, 8:941-947.
30. Symbas P.N., Cooper T., Gantner G.E., Willman V.L. Lymphatics of the heart: anatomic effects following interruption of the drainage of the cardiac lymph. Arch. Pathol. 1966, 81:573-575.
31. Symbas P.N., Schlant R.C., Gravanis M.B., Shepherd R.L. Pathologic and functional effects on the heart following interruption of the cardiac lymph drainage. J. Thorac. Cardiovasc Surg. 1969, 57:577-584.
32. Ullal S.R., Kluge T.H., Gerbode F. Functional and pathologic changes in the heart following chronic cardiac lymphatic obstruction. Surgery 1972, 71:328-334.
33. Rusznyak I., Foldi M., Szabo G. Lymphatics and Lymph Circulation 1960, Pergamon Press, New York.
34. Jacobs G., Kleinschmidt F., Benesch L., Lenz W., Uhlig G., Huth F. Tierexperimentalle Untersuchungen des kardialen Lymphgefass-System. Thoraxchirurgie 1976, 24:453-467. (in German).
35. Gloviczki P., Solti F., Szlavy L., Jellinek H. Ultrastructural and electrophysiologic changes of experimental acute lymphostasis. Lymphology 1983, 16:185-192.
36. Rubboli A., Sobotka P.A., Euler D.E. Effect of acute edema on left ventricular function and coronary vascular resistance in the isolated rat heart. Am. J. Physiol. 1994, 267:H1054-H1061.
37. Pick R., Miller A.J., Glick G. Myocardial pathology after cardiac venous and lymph flow obstruction in the dog. Am. Heart J. 1974, 87:627-632.
38. Solti F., Lengyel E., Jellinek H., Schneider F., Juhasz-Nagy A., Kekesi V. Coronary arteriopathy after lymphatic blockade: an experimental study in dogs. Lymphology 1994, 27:173-180.
39. Solti F., Iskum M., Nagy J., Hartai A., Veress B., Hüttner I., Kerényi T. The effect of mechanical lymph flow insufficiency on cardiac muscle necrosis as a result of coronary ligation. Cor. Vasa. 1968, 10:68-72.
40. Foldi M., Braun P., Papp M., Horvath I. Changes in serum transaminase activity following myocardial damage due to lymphatic congestion. Nature 1959, 183:1333-1334.
41. Cui Y. Pulmonary hemodynamic effects resulting from mediastinal lymphatic obstruction in anesthetized rabbits. Med. Sci. Res. 1999, 27:345-348.
42. Schraufnagel D.E. Forms of lung lymphatics: a scanning electron microscopic study of casts. Anat. Rec. 1992, 233:547-554.
43. Schraufnagel D.E., Agaram N.P., Faraqui A., Jain S., Jain L., Ridge K.M., Sznajder J.I. Pulmonary lymphatics and edema accumulation after brief lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 2003, 284:L891-L897.
44. Deitch E.A. Role of the gut lymphatic system in multiple organ failure. Curr. Opin. Crit. Care 2001, 7:92-98.
45. Szlavy L., Koster K., de Courten A., Hollenberg N.K. Early disappearance of lymphatics draining ischemic myocardium in the dog. Angiology 1987, 38:73-84.
46. Szlavy L., Adams D.F., Hollenberg N.K., Abrams H.L. Cardiac lymph and lymphatics in normal and infarcted myocardium. Am. Heart J. 1980, 100:323-331.
47. Taira A., Uehara K., Fukuda S., Takenaka K., Koga M. Active drainage of cardiac lymph in relation to reduction in size of myocardial infarction: an experimental study. Angiology 1990, 41:1029-1036.
48. Yotsmoto G., Moriyama Y., Yamaoka A., Taira A. Experiment study of cardiac lymph dynamics and edema formation in ischemia/reperfusion injury: with reference to the effect of hyaluronidase. Angiology 1998, 49:299-305.
49. Rockson S.G. Diagnosis and management of lymphatic vascular disease. J. Am. Coll. Cardiol. 2008, 52:799-806.
50. Adams R.H., Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Biol. 2007, 8:464-478.
51. Baluk P., McDonald D.M. Markers for microscopic imaging of lymphangiogenesis and angiogenesis. Ann. N.Y. Acad. Sci. 2008, 1131:1-12.
52. Oliver G., Alitalo K. The lymphatic vasculature: recent progress and paradigms. Annu. Rev. Cell Dev. Biol. 2005, 21:457-483.
53. Swartz M.A., Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Micros. Res. Tech. 2001, 55:92-99.
54. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 1996, 15:290-298.
55. Achen M.G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A.F., Alitalo K., Stacker S.A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flk4). Proc. Natl. Acad. Sci. U.S.A. 1998, 95:548-553.
56. Karpanen T., Egeblad M., Karkkainen M.J., Kubo H., Yla-Herttuala S., Jaattela M., Alitalo K. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 2001, 61:1786-1790.
57. Hong Y.K., Lange-Asschenfedt B., Velasco P., Hirakawa S., Kunsfeld R., Brown L.F., Bohlen P., Senger D.R., Detmar M. VEGF-A promotes tissue repair-associated lymphatic vessel formation via VEGFR-2 and the alpha1beta1 and alpha2beta1 integrins. FASEB J. 2004, 18:1111-1113.
58. Dixelius J., Makinen T., Wirzenius M., Karkkainen M.J., Wernstedt C., Alitalo K., Claesson-Welsh L. Ligand-induced vascular endothelial growth factor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites. J. Biol. Chem. 2003, 278:40973-40979.
59. Goldman J., Rutkowski J.M., Shields J.D., Pasquier M.C., Cui Y., Schmökel H.G., Willey S., Hicklin D.J., Pytowski B., Swartz M.A. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J. 2007, 21:1003-1012.